Forte Biosciences, Inc. (FBRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -18.81M | -16.47M | -14M | -10.06M | -10.36M | -10.01M | -8.13M | -5.94M | -6.67M | -8.97M | -9.06M | -5.47M | -5.2M | -2.89M | -1.94M | -1.38M | -1.98M | -3.58M | -5.13M | -3.94M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -81.63% | -64.51% | -72.14% | -69.49% | -55.32% | -11.6% | 10.21% | -8.42% | -28.11% | -210.02% | -366.91% | -297.6% | -163.49% | 19.24% | 62.16% | 65.03% | 50.99% | 5.81% | 33.75% | 1.94% |
| Net Income | -22.14M | -24.79M | -17.68M | -11.25M | -15.66M | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M | -9.96M | -8.9M | -6.75M | -4.88M | -3.4M | -3.04M | -2.57M | -3.34M | -7.75M | -5.81M |
| Depreciation & Amortization | 19K | 19K | 17K | 15K | 13K | 10K | 10K | 10K | 9K | 6K | 3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9K | 13K |
| Stock-Based Compensation | 3.18M | 1.66M | 1.48M | 1.5M | 1.62M | 697K | 791K | 802K | 805K | 780K | 772K | 855K | 877K | 860K | 906K | 1.19M | 1.05M | 1.24M | 1.47M | 1.01M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -7K | 1.05M | -6K | 0 | -240K | -156K | 9K | 3.58M | -6K | 8K | -118K | -21K | 0 | 0 | 0 | 0 | 0 | 0 | 61K | 0 |
| Working Capital Changes | 139K | 5.59M | 2.19M | -322K | 3.91M | -3.4M | -551K | 2.18M | -55K | -3.89M | 240K | 2.59M | 672K | 1.12M | 554K | 464K | -463K | -1.48M | 1.08M | 853K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.1M | 4.5M | 558K | -90K | 578K | -714K | -116K | 0 | 261K | -3.87M | 2.28M | 1.66M | 189K | 18K | 466K | 93K | -370K | -1.38M | 1.34M | -221K |
| Cash from Investing | 0 | 0 | -55K | 0 | 36.29M | -35.99M | 0 | 0 | -6K | -16K | 10.03M | -9.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | -55K | 0 | -61K | -31K | 0 | 0 | -6K | -17K | -71K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.96K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 74K | 9K | 1.32M | 70.35M | -2.32M | 51.88M | -2K | -10K | -8K | -75K | 24.78M | -24K | 6K | -55K | 7.44M | -110K | -34K | -39K | -3K | -29K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 101K | 15K | 1.33M | 70.35M | -2.31M | 53M | 5K | -10K | 8K | -64K | 24.82M | -24K | 6K | -55K | 7.28M | 0 | 12K | 1K | 19K | 15K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -2K | -1K | -10K | 0 | 0 | 0 | -24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -27K | -6K | -5K | -3K | -15K | -1.12M | -7K | 0 | -16K | -11K | -48K | 0 | 0 | 0 | 156K | -110K | -46K | -40K | -22K | -44K |
| Net Change in Cash | -18.73M | -16.46M | -12.73M | 60.29M | 23.61M | 5.88M | -8.13M | -5.95M | -1.33M | -9.06M | 706K | -15.46M | -5.2M | -2.95M | 5.5M | -1.49M | -2.01M | -3.62M | -5.13M | -3.97M |
| Free Cash Flow | -18.81M | -16.47M | -14.05M | -10.06M | -10.42M | -10.04M | -8.13M | -5.94M | -6.67M | -8.99M | -9.13M | -5.47M | -5.2M | -2.89M | -1.94M | -1.38M | -1.98M | -3.58M | -5.13M | -3.94M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -80.57% | -64% | -72.81% | -69.49% | -56.09% | -11.73% | 10.91% | -8.42% | -28.23% | -210.61% | -370.57% | -297.6% | -163.49% | 19.24% | 62.16% | 65.03% | 50.99% | 5.81% | 33.75% | 1.94% |
| FCF per Share | -0.11 | -0.11 | -0.79 | -0.86 | -0.91 | -1.57 | -4.40 | -3.22 | -4.29 | -6.18 | -6.03 | -6.50 | -6.19 | -3.44 | -2.56 | -2.33 | -3.35 | -6.07 | -9.00 | -7.24 |
| FCF Conversion (FCF/Net Income) | 0.85x | 0.66x | 0.79x | 0.89x | 0.66x | 1.40x | 0.97x | 0.47x | 0.90x | 1.53x | 0.91x | 0.62x | 0.77x | 0.59x | 0.57x | 0.45x | 0.77x | 1.07x | 0.66x | 0.68x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |